Apr 28, 2016 7:05am EDT Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference
Apr 20, 2016 7:05am EDT New Preclinical Study Shows Immunovaccine's DepoVax(TM)-Based Cancer Vaccine May Improve Efficacy of Checkpoint Inhibitors
Apr 15, 2016 7:05am EDT Immunovaccine Elects Medicago CEO Andy Sheldon as Board Chairman; Reports Results of the Annual General Meeting (AGM)
Apr 13, 2016 7:05am EDT Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Apr 11, 2016 5:05pm EDT Immunovaccine to Present New Pre-Clinical Data at the 2016 AACR Annual Meeting
Apr 07, 2016 7:05am EDT Immunovaccine and Leidos Join Forces to Develop a Zika Virus Vaccine Candidate
Mar 03, 2016 9:00am EST Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform
Jan 11, 2016 7:05am EST Immunovaccine Announces U.S. FDA, Health Canada Clearance to Initiate Phase 1b Clinical Trial for DPX-Survivac in Combination with Incyte's IDO1 Inhibitor Epacadostat in Recurrent Ovarian Cancer
